Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria De Santis

Showing results (131-140 of 278) with videos related to

Pageof 28
Sort By:
European Urology|December 31, 2013
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelinesJ Alfred Witjes, Eva Compérat, Nigel C Cowan, et al.
Scientific Reports|July 27, 2025
Metastasis directed radiotherapy versus standard of care for PSMA-PET diagnosed oligometastatic/oligoprogressive castration resistant prostate cancerLaura Bauersachs, Marcus Beck, Christian Furth, et al.
Annals of Hematology|August 23, 2024
Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexateMaria De Santis, Antonio Tonutti, Francesca Motta, et al.
World Journal of Urology|November 1, 2025
Epidemiology, treatment patterns and effectiveness of adherence to Bacillus Calmette-Guérin therapy in intermediate and high-risk non-muscle-invasive bladder cancer patients: a retrospective cohort analysis using German health claims dataJaime Luna, Eveline Otte Im Kampe, Heja Aga-Barfknecht, et al.
Clinical and Experimental Rheumatology|December 18, 2020
Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritisElena Generali, Maria De Santis, Natasa Isailovic, et al.
Annals of the Rheumatic Diseases|March 10, 2012
A vascular endothelial growth factor deficiency characterises scleroderma lung diseaseMaria De Santis, Silvia Laura Bosello, Ettore Capoluongo, et al.
Frontiers in Immunology|December 19, 2024
Serum IL-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritisMaria De Santis, Antonio Tonutti, Natasa Isailovic, et al.
Wiener Klinische Wochenschrift|August 30, 2008
[Chemotherapy for prostate cancer]Michael Rauchenwald, Maria De Santis, Eleonore Fink, et al.
EJNMMI Research|August 28, 2025
AI-driven body composition monitoring and its prognostic role in mCRPC undergoing lutetium-177 PSMA radioligand therapy: insights from a retrospective single-center analysisTristan Ruhwedel, Julian Rogasch, Markus Galler, et al.
European Urology|June 26, 2019
Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019Marc-Oliver Grimm, Axel Bex, Maria De Santis, et al.
Pageof 28

Showing results (131-140 of 278) with videos related to

Sort By:
Pageof 28
European Urology|December 31, 2013
EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelinesJ Alfred Witjes, Eva Compérat, Nigel C Cowan, et al.
Scientific Reports|July 27, 2025
Metastasis directed radiotherapy versus standard of care for PSMA-PET diagnosed oligometastatic/oligoprogressive castration resistant prostate cancerLaura Bauersachs, Marcus Beck, Christian Furth, et al.
Annals of Hematology|August 23, 2024
Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexateMaria De Santis, Antonio Tonutti, Francesca Motta, et al.
World Journal of Urology|November 1, 2025
Epidemiology, treatment patterns and effectiveness of adherence to Bacillus Calmette-Guérin therapy in intermediate and high-risk non-muscle-invasive bladder cancer patients: a retrospective cohort analysis using German health claims dataJaime Luna, Eveline Otte Im Kampe, Heja Aga-Barfknecht, et al.
Clinical and Experimental Rheumatology|December 18, 2020
Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritisElena Generali, Maria De Santis, Natasa Isailovic, et al.
Annals of the Rheumatic Diseases|March 10, 2012
A vascular endothelial growth factor deficiency characterises scleroderma lung diseaseMaria De Santis, Silvia Laura Bosello, Ettore Capoluongo, et al.
Frontiers in Immunology|December 19, 2024
Serum IL-23 levels reflect a myeloid inflammatory signature and predict the response to apremilast in patients with psoriatic arthritisMaria De Santis, Antonio Tonutti, Natasa Isailovic, et al.
Wiener Klinische Wochenschrift|August 30, 2008
[Chemotherapy for prostate cancer]Michael Rauchenwald, Maria De Santis, Eleonore Fink, et al.
EJNMMI Research|August 28, 2025
AI-driven body composition monitoring and its prognostic role in mCRPC undergoing lutetium-177 PSMA radioligand therapy: insights from a retrospective single-center analysisTristan Ruhwedel, Julian Rogasch, Markus Galler, et al.
European Urology|June 26, 2019
Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019Marc-Oliver Grimm, Axel Bex, Maria De Santis, et al.
Pageof 28